{"DataElement":{"publicId":"6423789","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Cancer Neoadjuvant Therapy Type","preferredDefinition":"Text term to identify the neoadjuvant therapy type used to treat liver cancer.","longName":"LIVER_CANCER_TXT_TYPE","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6423682","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Carcinoma Neoadjuvant Therapy","preferredDefinition":"A carcinoma that arises from the hepatocytes or intrahepatic bile ducts.  The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma._The administration of therapeutic agents prior to the primary treatment for the purpose of making the primary treatment more effective.","longName":"3179609v1.0:6423680v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"3179609","version":"1","preferredName":"Liver and Intrahepatic Biliary Tract Carcinoma","preferredDefinition":"A disease in which malignant (cancer) cells are found in the tissues of the liver.","longName":"C7927","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver and Intrahepatic Bile Duct Carcinoma","conceptCode":"C7927","definition":"A carcinoma that arises from the hepatocytes or intrahepatic bile ducts.  The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A7B501-CBB5-2349-E040-BB89AD430DBA","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"ONEDATA","dateModified":"2010-12-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6423680","version":"1","preferredName":"Neoadjuvant Therapy","preferredDefinition":"The administration of therapeutic agents prior to the primary treatment for the purpose of making the primary treatment more effective.","longName":"C15665","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"751214BE-3D69-159A-E053-F662850ADC39","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-04","modifiedBy":"ONEDATA","dateModified":"2018-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"751214BE-3D7A-159A-E053-F662850ADC39","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-04","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer CDE request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6423746","version":"1","preferredName":"Liver and Bile Duct Cancer Neoadjuvant Therapy Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6423746v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520EB61-DCA8-23B7-E053-F662850A69F9","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Transarterial chemoembolization (TACE)","valueDescription":"Transarterial Chemoembolization","ValueMeaning":{"publicId":"5622072","version":"1","preferredName":"Transarterial Chemoembolization","longName":"5622072","preferredDefinition":"A hepatic artery embolization technique involving the injection of a blocking agent and a chemotherapy agent to treat liver cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transarterial Chemoembolization","conceptCode":"C101513","definition":"A hepatic artery embolization technique involving the injection of a blocking agent and a chemotherapy agent to treat liver cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45BEAC9E-5F4F-170A-E053-F662850AB6A3","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520EB61-DCBC-23B7-E053-F662850A69F9","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Thermal ablation","valueDescription":"Thermal Ablation Therapy","ValueMeaning":{"publicId":"6423748","version":"1","preferredName":"Thermal Ablation Therapy","longName":"6423748","preferredDefinition":"A procedure using heat to remove tissue or a part of the body, or destroy its function.  For example, to remove the lining of the uterus, a catheter is inserted through the cervix into the uterus, a balloon at the end of the catheter is inflated, and fluid inside the balloon is heated to destroy the lining of the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thermal Ablation Therapy","conceptCode":"C15670","definition":"A procedure using heat to remove tissue or a part of the body, or destroy its function.  For example, to remove the lining of the uterus, a catheter is inserted through the cervix into the uterus, a balloon at the end of the catheter is inflated, and fluid inside the balloon is heated to destroy the lining of the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520EB61-DCC8-23B7-E053-F662850A69F9","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520EB61-DCE1-23B7-E053-F662850A69F9","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75213FFF-EB50-0994-E053-F662850A5667","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"6403794","version":"1","longName":"HCC and Bile Duct Cancer","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Liver cancer neoadjuvant ther","type":"Preferred Question Text","description":"Liver cancer neoadjuvant therapy type","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75219A43-3EBC-42C3-E053-F662850A55EA","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}